Morgan Stanley Has Lowered Expectations for Illumina (NASDAQ:ILMN) Stock Price
Illumina (NASDAQ:ILMN – Get Free Report) had its target price reduced by stock analysts at Morgan Stanley from $150.00 to $136.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the life sciences company’s stock. Morgan Stanley’s price objective suggests a potential upside of 31.31% from the […]
Illumina (NASDAQ:ILMN – Get Free Report) had its target price reduced by stock analysts at Morgan Stanley from $150.00 to $136.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the life sciences company’s stock. Morgan Stanley’s price objective suggests a potential upside of 31.31% from the […]
